QA: Vertex Pharmaceuticals INC MA in us_pharma/2012

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000875320_2013_Vertex_Pharmaceuticals_INC_MA.pdf

Logs

Graph

Absolute values for 0000875320, Vertex Pharmaceuticals INC MA

  xvar xval
0 AssetsCurrent 1,589,585,000
1 IntangibleAssetsNetIncludingGoodwill 30,992,000
2 PropertyPlantAndEquipmentNet 433,609,000
3 remainder_Assets 705,102,000
4 LiabilitiesCurrent 432,624,000
5 LiabilitiesNoncurrent 13,902,000
6 remainder_Liabilities 1,078,380,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 436,796,000
9 ResearchAndDevelopmentExpense 806,185,000
10 remainder_Expenses 337,136,000
11 remainder_Revenues 1,527,042,000
12 remainder_NetIncome 1,940,000
13 remainder_ComprehensiveNetIncome -55,394,000
  yvar yval
0 Assets 2,759,288,000
1 Liabilities 1,524,906,000
2 Expenses 1,580,117,000
3 Revenues 1,527,042,000
4 StockholdersEquity 1,234,382,000
5 NetIncome -51,135,000
6 ComprehensiveNetIncome -78,832,000
7 BaseVar 3,724,343,500
8 EconomicCapitalRatiobeforeLimitedLiability 1.22
9 EconomicCapitalRatio 2.47

Edgar->Model Mapping

Feature Distribution

Change over Time